Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist-Reference-Cited by-同舟云学术

Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist

Published:2018-05-21 Issue:7 Volume:2 Page:821-835
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Erstad Derek J.¹^ORCID,Farrar Christian T.²,Ghoshal Sarani¹,Masia Ricard³,Ferreira Diego S.²,Chen Yin‐Ching Iris²,Choi Ji‐Kyung²,Wei Lan¹,Waghorn Phillip A.²,Rotile Nicholas J.²,Tu Chuantao²,Graham‐O'Regan Katherine A.²,Sojoodi Mozhdeh¹,Li Shen¹,Li Yang⁴,Wang Guogiang⁴,Corey Kathleen E.⁵,Or Yat Sun⁴,Jiang Lijuan⁴,Tanabe Kenneth K.¹,Caravan Peter²⁶,Fuchs Bryan C.¹

Affiliation:

1. Division of Surgical Oncology, Massachusetts General HospitalHarvard Medical SchoolBoston MA

2. Martinos Center for Biomedical Imaging, Massachusetts General HospitalHarvard Medical SchoolCharlestown MA

3. Department of Pathology, Massachusetts General HospitalHarvard Medical SchoolBoston MA

4. Enanta PharmaceuticalsWatertown MA

5. Department of Medicine, Massachusetts General HospitalHarvard Medical SchoolBoston MA

6. Institute for Innovation in ImagingMassachusetts General HospitalBoston MA

Funder

National Institutes of Health

Publisher

Wiley

Subject